US markets New York
Stocks

Beyond Market Cap: How Rob Arnott Is Hunting For Undervalued Giants

Beyond Market Cap: How Rob Arnott Is Hunting For Undervalued Giants

Investment veteran Rob Arnott is shaking up his approach to the markets with the launch of Syzygy Asset Management, a rebranded venture born from the sale of his Research Affiliates business. Rather than following the crowd by focusing on market capitalization, Arnott is doubling down on a strategy centered around actual sales volume. He argues that traditional indexes often lead investors to overpay for stocks simply because they are large in price, regardless of whether their underlying revenue justifies that premium. By prioritizing top line growth and reasonable valuations, Syzygy seeks to find massive companies that the rest of the street has overlooked.

Applying this logic, Arnott has identified several heavy hitters that he believes are flying under the radar of mainstream growth indexes. Among these are banking powerhouse JPMorgan Chase and pharmaceutical leader Merck. According to Arnott, both companies possess impressive growth trajectories that aren’t fully recognized by standard benchmarks like the Russell Growth index. Because these firms maintain strong fundamentals without carrying exorbitant price tags, they fit perfectly into his vision of affordable growth.

Beyond finance and healthcare, Arnott is placing a significant bet on energy through Cheniere Energy, the global leader in natural gas production. To illustrate why he finds the stock attractive, Arnott pointed out a stark contrast between Cheniere and other popular names in the S&P 500. Specifically, he noted that while Cheniere generates five times the revenue of software firm Palantir, it trades at a fraction of its market value. It is this kind of disconnect between real economic scale and market pricing that drives Arnott’s current conviction across his core, growth, and value portfolios.